Neumora Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
General Public | 7,928,021 | 4.91% |
Individual Insiders | 9,340,108 | 5.78% |
VC/PE Firms | 31,932,138 | 19.8% |
Public Companies | 35,368,653 | 21.9% |
Institutions | 76,992,144 | 47.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
35,368,653 | US$342.0m | 0% | no data | |||
31,932,138 | US$308.8m | 0% | 31.25% | |||
7,861,859 | US$76.0m | 0% | 100.0% | |||
7,646,916 | US$73.9m | 0% | no data | |||
7,546,916 | US$73.0m | -1.31% | 1.76% | |||
6,186,894 | US$59.8m | 34.4% | no data | |||
5,853,811 | US$56.6m | 1.44% | no data | |||
4,460,700 | US$43.1m | 0% | 6.1% | |||
4,377,166 | US$42.3m | 33.7% | no data | |||
4,218,265 | US$40.8m | -25% | 22.77% | |||
3,530,891 | US$34.1m | 17.8% | no data | |||
3,398,628 | US$32.9m | 0% | 0.61% | |||
3,309,123 | US$32.0m | 0% | 0.35% | |||
2,606,571 | US$25.2m | -7.7% | 0.65% | |||
2,071,450 | US$20.0m | 0% | 0.68% | |||
1,979,847 | US$19.1m | 54% | no data | |||
1,849,445 | US$17.9m | 0% | 4.03% | |||
1,800,000 | US$17.4m | 0% | 0.96% | |||
1,790,707 | US$17.3m | 65.3% | no data | |||
1,500,000 | US$14.5m | 0% | 0.2% | |||
1,034,600 | US$10.0m | 0% | 0.09% | |||
828,101 | US$8.0m | 8.96% | 0.26% | |||
698,255 | US$6.8m | 140% | no data | |||
682,383 | US$6.6m | 389% | no data | |||
676,244 | US$6.5m | 0% | 0.02% |